Brief: Rani Therapeutics Reports Q1 2022 Results
May 11 (Reuters) - Rani Therapeutics Holdings Inc RANI.O :
* RANI THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS;
PROVIDES CORPORATE UPDATE
* RANI THERAPEUTICS HOLDINGS INC - QTRLY LOSS PER SHARE
$0.29
Source text for Eikon: ID:nGNX4qHPwD
Further company coverage: RANI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rani Therapeutics Holdings
See all newsRani Therapeutics Q2 net loss narrows as revenue rises helped by Chugai agreement
Brief: Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: Rani Therapeutics Announces R&D Collaboration With PegBio
Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition